Advertisement

Topics

Latest "Ghirardelli Chocolate Company" News Stories

11:53 EDT 17th July 2018 | BioPortfolio

Here are the most relevant search results for "Ghirardelli Chocolate Company" found in our extensive news archives from over 250 global news sources.

More Information about Ghirardelli Chocolate Company on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Ghirardelli Chocolate Company for you to read. Along with our medical data and news we also list Ghirardelli Chocolate Company Clinical Trials, which are updated daily. BioPortfolio also has a large database of Ghirardelli Chocolate Company Companies for you to search.

Showing "Ghirardelli Chocolate Company" News Articles 1–25 of 15,000+

Tuesday 17th July 2018

Venture Verde and the Chicago Mushroom Company to Open a Controlled Environment Agricultural Facility in Chicago

Facility to Help Drive New Sustainability Standards for Indoor Urban Farming Venture Verde, a real estate, land and water management company focused on driving sustainability, announced it signed an agreement with the


One of Nation’s Largest Home-Based Care Providers to Rebrand as “Elara Caring”

Following the Combination of Great Lakes Caring, National Home Health Care, and Jordan Health Services, Unified Company Adopts New Name and Branding Today, the newly formed company that combines Great Lakes Caring, National Home Health Care, and Jordan Health Services announced it will be named Elara Caring. In April, these three award-winning health c...

Oxford Immunotec Schedules Second Quarter 2018 Earnings Release and Conference Call for July 31, 2018

OXFORD, United Kingdom and MARLBOROUGH, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it plans to release second quarter 2018 financial results prior to market open on Tuesday, July 31, 2018. Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will h...


Independent/Provider-Sponsored Administrative Costs Accelerated in 2017

Independent/Provider-Sponsored health plans had administrative cost increases of 5.5% in 2017, the highest since 2013. Last year’s increase was 2.4%. Increases are calculated for continuously participating plans, after backing out the effect of mix changes. On an as-reported basis, per member costs grew by 5.2% compared with 3.0% in the prior ye...

Global Medical REIT Inc. Schedules 2018 Second Quarter Financial Results Conference Call

Conference Call Scheduled for Wednesday, August 8, 2018 at 9:00 a.m. ET Global Medical REIT Inc. (NYSE:GMRE) (the “Company”), a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share, ...

American Shared Hospital Services Selects PCG Advisory Group for Investor Relations and Strategic Communications

American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced that it has retained PCG Advisory Group, a leading investor relations and digital strategies firm, to serve as an advisor for investor relations and strategic c...

Jamieson Wellness Inc. Announces Date of Second Quarter 2018 Financial Results and Conference Call

Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that the Company will release its second quarter 2018 financial results after the market close on Wednesday, August 8, 2018. The Company will host a conference call for investors at 5:00 p.m. Eastern Time to discuss the second quarter 2018 results. The call ca...

TripleCare Brings Physician-Based Telemedicine Services to Commonwealth Care of Roanoke

Services to Roll out in all 12 Commonwealth Care Locations; Three Initially in the 2018 Third Quarter with Nine to be Completed by Year-end TripleCare, a national provider of telemedicine-based healthcare to the post-acute care sector, including skilled nursing facilities (SNFs), announced today the Company will introduce its services across all

Sunovion to Launch Take On Tomorrow™ Giving Opportunity with Red Sox Foundation and 7th Annual Community Service Program

Expecting to Reach 25,000 Cumulative Employee Volunteer Hours This Summer, Company Will Mark Milestone by Donating $25,000 to Support Education and Mental Health Initiatives Sunovion Pharmaceuticals Inc. (Sunovion), a partner of the Boston Red Sox, today announced that the Company is continuing its a

22nd Century Announces the Immediate Feasibility of the FDA’s Nicotine Reduction Plan

Reynolds American and Phillip Morris unable to comply with the FDA’s plan “for 20-years” 22nd Century Group, Inc. (NYSE American:XXII), a plant biotechnology company that is a leader in tobacco harm reduction and Very Low Nicotine tobacco, yesterday responded to the Advance Notice of Proposed Rulemaking (

Can-Fite Granted Australian and Chinese Patents for Erectile Dysfunction Drug

Erectile dysfunction market is estimated to reach $3.2 billion by 2022 Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address liver diseases, inflammatory diseases and sexual dysfunction, today announced that the Australian and Chinese patent offices have ...

Co-Diagnostics Completes Submission of CE Mark Registration for Tuberculosis Screening Test

Company’s Logix Smart™ MTB Test to be available for purchase with CE mark in August 2018 Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ MTB Test technical file has been submitted for registra...

MOLOGEN AG: Resolved reverse share split implemented

DGAP-News: MOLOGEN AG / Key word(s): Corporate Action 17.07.2018 / 10:16 The issuer is solely responsible for the content of this announcement. Press release No. 15/2018 on 17 July 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNL...

APEIRON Appoints Peter Llewellyn-Davies as Chief Executive Officer

DGAP-News: APEIRON Biologics AG / Key word(s): Change of Personnel 17.07.2018 / 10:00 The issuer is solely responsible for the content of this announcement. APEIRON Appoints Peter Llewellyn-Davies as Chief Executive Officer The former CEO Dr. Hans Loibner will continue to support the Company as senior advisor Vienna, Austria, 17 July 2018: APEIRON Biologics AG, a company focused on ca...

Innovus Pharmaceuticals Reports Preliminary Q2 2018 Sales Revenue of $6.6 million to $6.8 million

Preliminary Quarterly Revenue Increase of 47-51% and Comparable 2017 Second Quarter Increase of 330-340% and Fiscal Year 2018 Net Revenue Annual Guidance Adjusted Upwards to at Least $22 Million Innovus Pharmaceuticals, Inc., (“Innovus Pharma”) (OTCQB: INNV), today announced preliminary second quarter 2018 net revenue is estimated to be between $6....

H.I.G. Capital Signs Definitive Agreement for the Sale of AMPAC Fine Chemicals

H.I.G. Capital (“H.I.G.”), a leading global private equity investment firm with more than $25 billion of equity capital under management, is pleased to announce the signing of a definitive agreement for the sale of its portfolio company AMPAC Fine Chemicals (“AFC” or the “Company”) to SK Holdings Co. Ltd. Based in Rancho Cordova, CA, A...

Update on Progress of Broad Spectrum Antibiotic RECCE®327 Towards Clinical Trials

SYDNEY, Australia - 17 July 2018 - Recce Pharmaceuticals Ltd (ASX:RCE) (Company), the Company developing a new class of synthetic, broad spectrum antibiotics, today provided an update on its progress towards the start of human trials of its lead compound RECCE®327, for the treatment of sepsis, including a simple clinical trial design. RECCE®327 is being developed as a new class of a...

Enzymatica AB: Lower sales in Q2 but 31% increase for the first half of the year

                                                                                       Interim report for Enzymatica AB (publ)                                                                                ...

CellaVision AB: Interim Report January-June 2018

Good sales growth in all regions April 1-June 30, 2018 Net sales increased by 17% to SEK 91.9 million (78.7). Organic growth was 15%. Operating profit was SEK 31.6 million (24.6). Operating margin was 34.4% (31.3). Earnings before tax were SEK 31.8 million (24.2). Earnings per share were SEK 0.98 (0.81). Cash flow before dividend was SEK 26.1 million (11.2). January 1-...

Terveystalo Plc: The Finnish Competition and Consumer Authority initiates further proceedings concerning the transaction between Terveystalo and Attendo

Terveystalo Plc Stock Exchange release 17 July 2018 at 09.00 a.m. EEST Terveystalo Plc ("Terveystalo") has on 17 May 2018 signed an agreement to acquire the Finnish healthcare operations of Attendo AB (publ) ("Attendo") (the "Transaction"). The Transaction was announced in Terveystalo's stock exchange release of 17 May 2018. The completion of the Transact...

Slone Partners, Where People Are Our Science™, Places New Chief Medical Officer, Garrett K. Lam M.D. FACOG, at Sera Prognostics, Inc.

Successful nationwide search secures former professor and Chairman of the Department of Obstetrics & Gynecology at the University of Tennessee College of Medicine-Chattanooga, who will direct all clinical development activities for The Pregnancy Company™ BOSTON (PRWEB) July 17, 2018 Slone Partners, North America’s leading executive search firm for life sciences, diagnostics and scientific...

argenx receives milestone payment from strategic collaboration with Shire

July 17, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, today announced that it has reached a preclinical milestone in its strategic collaboration with Shire plc. The milestone...

#jobs #lifescience Executive Assistant to CEO

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Executive Assistant to CEO .MA-Cambridge, Executive Assistant to the CEO – Join a Thriving Biotech Company, $110k+ and Stock! (A1128041) Our client, an extremely successful biotechnology company in … Continue reading → Cet article #jobs #lifescience Executive...

Global Vitamin Fortified and Mineral Enriched Food Beverage Market Growth, Trend and Forecast 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The vitamin fortified and mineral enriched food beverage market was estimated to be USD 250.99 billion in 2015, and is expected to register a CAGR of 7.9% during the forecast period 20182023. Food fortification is attractive because it does not require the target groups to change their diet but can be implemented by the food industry and because it reaches large numbers of consumers through retai...

Monday 16th July 2018

Global Whiskey Market Growth, Trends, and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $1923

The global whisky market is expected to reach USD 7.40 billion by 2023, witnessing a CAGR of 5.3% during 20182023 forecast period. Whiskey is considered as an affordable luxury item, leading many whiskey manufacturing companies to launch more premium and super premium products in the market. As a product innovation, the brewing industry is launching an organic whiskey without any artificial colors...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks